30 September 2009

Immunoassays



Immunoassays
By:Diane C. Jette, Ph.D.
BioMedica Diagnostics Inc.

Test Menu
* Infectious Diseases
* Cardiac Markers
* Cancer Screening
* Fertility / Hormones
* Drugs of Abuse
* Other Tests
o IgE
o Rh Factor
o Occult Blood
o TSH, T3, T4
o Blood Grouping

Test Formats Available
* Latex Agglutination
* DIPSTICK
* Card Format
* Cartridge Format
* ELISA Format with Plate Reader

Structure of IgG
(150,000 Daltons)
Antigen
Binding Site
Fab
Fc

Structure of IgM
(900,000 Daltons)
Binding Sites
Sandwich ELISA Procedure
* Antibody coated on plate.
* Incubate with sample containing antigen.
* Wash away unbound material.
* Incubate with antibody-enzyme conjugate.
* Wash away unbound conjugate.
* Add substrate.
* Enzyme acts on substrate and produces color change.
* Measure amount of color produced.
* Amount of antigen present is proportional to the amount of color produced.

ELISA: Sandwich Format
Sandwich Assay Results
Color Intensity (OD)
Antigen Concentration
Linear Range
ELISA: Inhibition Assay Procedure
* Antigen coated on plate.
* Incubate with sample containing antigen and enzyme-antibody conjugate.
* Antigen in solution binds to enzyme-antibody conjugate preventing binding to antigen on plate.
* Wash away all unbound material.
* Add substrate.
* Enzyme acts on substrate to produce a color change.
* Measure the amount of color.
* The amount of antigen present is inversely proportional to the amount of color produced.
ELISA: Inhibition Format
Inhibition Assay Results
Color Intensity (OD)
Antigen Concentration
Linear Range
Agglutination Assay Procedure
Antibody Detection
* Antigen coated on latex particles.
* Incubate with sample containing antibody.
* Antibody binding to antigen causes cross-linking of latex beads.
* Agglutination is observed.
Antigen Detection
* Antibody coated on latex particles.
* Incubate with sample containing antigen.
* Antigen binding to antibody causes cross-linking of latex beads.
* Agglutination is observed.
Latex Agglutination Assay
Latex Agglutination
Negative Result
Smooth gray appearance
Positive Result
Large aggregates in the center or periphery of the test circle
DIPSTICK Format
Absorbing Pad
Test Area
Maximum Level
Sample Pad
Negative Result
Positive Result
CARD Format
CONTROL
TEST
SAMPLE
Negative Result
CONTROL
TEST
SAMPLE
Positive Result
Cartridge Format
Negative Result
S T C
Positive Result

Immunoassays.ppt

Read more...

Urine Analysis



Urine Analysis
By:Diane C. Jette, Ph.D.
BioMedica Diagnostics Inc.


Reagent Test Strips
* Multiple test reagents on a ready to use test strip.
* Test results are read at different times after brief exposure to urine sample.
* The color on strip is compared to the reference color shown on test strip packaging.

Typical Test Strip Test
Glucose
Bilirubin
Ketone
Blood
Protein
Nitrite
Leukocytes
pH
Specific Gravity
Urobilinogen
Sensitivity_
* 4 to 7 mmol/L
* 7 to 14 mol/L
* 0.5 to 1.0 mmol/L (Acetoacetic acid)
* 150 to 620 g/L (Hemoglobin)
* 0.15 to 0.3 g/L (Albumin)
* 13 to 22 mol/L
* 5 to 15 cells/ L
* pH 5.0 to 8.5
* 1.000 to1.030
* 0.2 to 8 mol/L

Glucose
* Small amounts of glucose normally excreted by the kidney.
* Below sensitivity of the test.
* >6 mmol/L clinically significant.

Bilirubin
* Normally no Bilirubin is detected in urine.
* Even trace amounts are clinically significant.
Ketones
* Test detects acetoacetic acid in urine.
* Normal urine negative with this test.
* Detectable levels seen during physiological stress such as fasting, pregnancy, and frequent strenuous exercise.
* Large amounts with ketoacidosis due to starvation and abnormal carbohydrate or lipid metabolism.
Specific Gravity
* Range = 1.000 and 1.030
* Elevated specific gravity seen with elevated protein levels (1 to 7.5 g/L)

Blood
* Test measures hemoglobin and myoglobin.
* Trace amounts may be clinically significant.
* Often found in urine of menstruating females.
* False positives may be seen with urinary tract infections

pH
* Range from pH 5 to 8.5.
* False results may occur if excessive urine remains on the strip.

Protein
* Test sensitive to albumin.
* Negative result does not rule out the presence of hemoglobin or globulins.
* Normally no protein present in urine.
* Greater than 0.3 g/L is clinically significant.

Urobilinogen
* Normal Range in urine = 3 to 17 mol/L
* Greater than 34 mol/L transition from normal to abnormal.
* Total absence of urobilinogen cannot be determined with this test.
Nitrite
* Dependant on the conversion of dietary nitrate to nitrite by Gram Negative Bacteria.
* Positive results may indicate presence of greater than 105 cells per mL.
* Color not proportional to the number of cells.

Leukocytes
* Normally no leukocytes present in urine.
* Positive result is clinically significant.
* Some drugs interfere with the test

Urine Analysis.ppt

Read more...

29 September 2009

Andrews’ Diseases of the Skin



Andrews’ Diseases of the Skin
By:Boris Ioffe, D.O.

Recalcitrant Palmoplantar Eruptions

* Recalcitrant pustular eruptions of the hands and feet are often examples of psoriasis
* Need to then search for lesions elsewhere on the body(e.g., scalp, ears, glans penis)
* Search also for a family history to confirm your suspicion

Dermatitis Repens
* Aka- acrodermatitis continua and acrodermatits perstans
* It’s a chronic inflammatory disease of hands and feet
* Rarely, can become generalized
* Usually, as a pustule or paronychia
* Occasionally, mucous membranes are involved
* Nails are often dystrophic or destroyed
* Lesions cause skin atrophy
* Crusted, eczematoid, and psoriasiform lesions may occur, and there may be moderate itching
* It is essentially unilateral in its beginning and asymmetrical throughout its entire course
* Histology
o similar to those seen in psoriasis
o the primary lesion is epidermal
o An intraepithelial spongiform pustule is formed by infiltration of pmn’s
* Treatment
o topical mechlorethamine, topical steroids, PUVA, fluorouracil, and sulfapyridine
o Acitretin, low dose cyclosporine, Acitretin plus calcipotriol

Palmoplantar Pustulosis
* AKA pustular psoriasis
* In contrast to dermatitis repens it is essentially bilateral and symmetrical
* Locations include: thenar/hypothenar eminences or central portion of the palms and soles
* Patches begin as erythematous areas in which pustules form
* Start as pinhead-sized, enlarge and coalesce to form small lakes of pus
* In the course of a week, they tend to dry up, leaving punctate brown scabs that eventually exfoliate
* Stages of quiescence and exacerbation characterize the condition
* Meds, such as lithium, have been reported to induce
* Nails may become malformed, ridged, stippled, pitted and discolored
* May be associated with psoriasis vulgaris
* Some regard palmoplantar pustulosis as a form of psoriasis, while others consider it a separate entity
* Female predominance; lack of seasonal variation; different histopathologic features and
* Associated with thyroid disorders and cigarette smoking
* May be predisposed to joint disease and possibly SAPHO syndrome-Synovitis, Acne, Pustulosis, Hyperostosis and Osteoarthritis
* It’s resistant to most treatments
* Acitretin is reportedly effective(1mg/kg/day)
* Low-dose cyclosporine (1.25mg/kg/day-3.75mg/kg/day)
* Intramuscular Kenalog (40-60mg)may be effective for short-term relief

Pustular Bacterid
* Characterized by a symmetric, grouped, vesicular or pustular eruption on palms and soles
* Marked by exacerbations and remissions over long periods
* No involvement of webs of fingers or toes or flexion creases of toes
* WBC may be elevated
* Scaling is usually present
* Etiology is thought to be a remote focus of infection; infection needs to be treated before resolution will occur

Juvenile Plantar Dermatosis
* Usually begins as a patchy, symmetrical, smooth, red, glazed macule on great toes, sometimes with fissuring and desquamation in children aged 3-13
* Toe webs are rarely involved; fingers may be
* Histologically, there is psoriasiform acanthosis and a sparse, lymphocytic infiltrate in the upper dermis
* Spongiosis is commonly present
* Tx: bed rest, cotton socks and topical steroids
* Spontaneous resolution within 4 yrs is the rule

Infantile Acropustulosis
* Intensely itchy vesicopustular eruption of hands and feet
* Begins at any age up to 10 months, clearing in a few weeks and recurring repeatedly until final resolution at 6 – 36 months of age
* Dapsone at 2mg/kg/day may help
* Potent topical steroids aid in symptomatic relief
* Should prompt an extensive workup to eliminate serious infectious causes (i.e., Tzanck prep, gram stain, KOH prep of pustule)
* Some suspect that this condition may be a persistent reaction to prior scabies

Infantile Acropustulosis
* Acropustulosis of infancy
Pompholyx
* AKA dyshidrosis
* A vesicular eruption of palms and soles characterized by spongiotic intraepidermal vesicles and often accompanied by burning or itching
* Hyperhidrosis may be present
* Usually bilateral and symmetrical
* Bullae may form
* Contents are clear and colorless
* Attacks generally last a few weeks
* Lesions dry-up and desquamate rather than rupture
* Etiology- stress, atopy, and topical as well as ingested contactants
* Histopathology: spongiotic vesicles in the epidermis
* Differential dx:
o dermatophytid, contact dermatitis, atopic dermatitis, drug eruption, pustular psoriasis of palms and soles, acrodermatitis continua, and pustular bacterid
* Rarely, T-cell lymphoma can present with similar clinical findings, but biopsy of the vesicles will be diagnostic
* Tx: high potency corticosteroid creams
* Triamcinolone acetonide intramuscularly or a short course of oral prednisone is rapidly effective
* Oral or topical psoralen + UVA (PUVA) is effective but costly & inconvenient
* In more severe forms, immunosuppressive mycophenolate mofetil has been effective

Lamellar Dyshidrosis
* AKA dyshidrosis lamellosa, keratolysis exfoliativa
* A superficial exfoliative dermatosis of the palms and sometimes soles
* Referred to as recurrent palmar peeling
* Involvement is bilateral
* Can occur in association with dyshidrosis
* Often exacerbated by environmental factors
* Differential dx: dermatophytosis, chronic contact dermatitis
* Tx: difficult
* Spontaneous involution can occur in a few weeks for some
* Most tends to be chronic and relapsing
* Tar creams (Zetone cream) usually helps
* 5% tar in gel (Estar Gel) is an excellent tx
* Lac-Hydrin lotion and Carmol 10 or 20 are often effective
* NB-UVB may be helpful

Palmoplantar Keratoderma
* AKA tylosis, keratosis, hyperkeratosis
* Characterized by excessive formation of keratin on the palms and soles
* Acquired
o Keratosis Punctata of the Palmar Creases
o Punctate Keratoses of the Palms and Soles
o Porokeratosis Plantaris Discreta
o Keratoderma Climactericum
* Congenital


Punctate Keratosis of the Palms and Soles
* Primary lesion is a 1-5mm round to oval, dome-shaped papule distributed over left hand and hypothenar eminence
* Main symptom is pruritis
* Lesions number from 1 to >40
* Affects mainly blacks
* There’s a potential risk of developing lung and colon cancer

Keratosis Punctata of the Palmar Creases
* Common most often in black pts
* Primary lesion is a 1-5mm depression filled with a conical keratinous plug
* Primarily, in creases of palms or fingers, occasionally in soles
* Lesions are multiple
* Friction aggravates lesions causing them to become verrucoid or surrounded by callus
* Punctate keratoses of the palmar creases in an African-American
* PPPK-punctate palmoplantar keratoderma

Porokeratosis Plantaris Discreta
* Occurs in adults, Female:Male (4:1)
* Characterized by sharply marginated, rubbery, wide-based papule that does not bleed on removal
* Lesions are multiple, painful, 7-10mm in diameter
* Usually on wt bearing areas of sole, beneath metatarsal heads
* Tx: foot pads to redistribute wt, surgical excision, blunt dissection

Keratoderma Climactericum
* Characterized by hyperkeratosis of palms and soles beginning at about the time of menopause
* Descrete, thickened, hyperkeratotic patches most pronounced at pressure sites
* Fissuring may be present
* Tx: keratolytics -- 10% salicylic acid, lactic acid creams, etc.

Hereditary syndromes
* These have palmoplantar keratoderma as a feature
o Unna-Thost
o Papillon-Leferve
* Dominant inheritance; congenital thickening of epidermal horny layer of the palms and soles
* Usually symmetrical
* Epidermis becomes thick, yellowish, verrucous, and horny
* Striate and punctate forms occur

Unna Thost
* Occasionally nails become thickened
* 5% salicylic acid may help
* Lac Hydrin 12% may be tried
* Acitretrin or isotretinoin may be considered, but need for lifetime tx makes them impractical
* Focal palmoplantar keratosis of the striate type on the sole
* Diffuse non-epidermolytic palmoplantar keratosis
* Diffuse epidermolytic palmoplantar keratosis with diffuse hyperkeratosis

Papillon-Lefevre Syndrome
* Palmoplantar hyperkeratosis with peridontosis
* Usually develops within the first few months of life but may occur in childhood
* Well demarcated, erythematous, hyperkeratotic lesions on palms and soles
* Transverse grooves of fingernails may occur
* Early onset peridontal disease has been attributed to damage and alteration in PMN function caused by Actinomyces actinomycetemcomitans
* Disease associations include: acroosteolysis, and pyogenic liver abcesses
* There are asymptomatic ectopic calcifications in the choroid plexus and tentorium
* Therapy may retard both dental and skin abnormalities
* Treatment with Acitretin in four siblings was reported to be effective

Papillon-Lefevre Syndrome
* Papillon-Lefevre syndrome: plantar keratoderma

Mutilating Keratoderma of Vohwinkel
* Palmoplantar hyperkeratosis of the honeycomb type-associated with starfish-like keratosis on backs of hands and feet; linear keratoses of the elbows and knees, and annular constriction (pseudo-ainhum) of the digits, this may progress to autoamputation
* More than 30 cases have been reported world-wide
* More common in women and in whites
* Onset is in infancy or early childhood
* Vohwinkel’s mutilating syndrome: A.) diffuse keratoderma of palms with B.) pseudoaainhum formation

Palmoplantar Keratodermas & Malignancy
* Diffuse, waxy keratoderma of palms and soles occurring as an AD trait associated with esophageal carcinoma
* Other related factors are oral leukoplakia, esophageal srictures, squamous carcinoma of tylotic skin, carcinoma of larynx and stomach
* Acquired forms of palmoplantar keratodermas have also been associated with carcinoma of esophagus, lung, breast, bladder and stomach
* Focal PPK in association with carcinoma of the esophagus

Acrokeratoelastoidosis of Costa
* AD, more common in women
* Small, round, firm papules occurring over dorsal hands, knuckles, and lateral margins of palms and soles
* Appears in early childhood and progress slowly
* Most often asymptomatic
* Significant histologic finding is dermal elastorrhexis
* Therapies: liquid nitrogen, salicylic acid, tretinoin, and prednisone have been tried
* Focal acrokeratoelastoides: multiple skin-colored papules at the margin of the palmar skin
* Path: non-epidermolytic palmoplantar keratosis, acanthosis and hypergranulosis

Exfoliative Dermatitis
* Universal or very extensive scaling and itching erythroderma
* Often associated with hair loss
* Initially with erythematous plaques, which spread rapidly
* Onset accompanied by general toxicity
* Skin becomes scarlet and swollen and may ooze a straw-colored exudate
* Desquamation is evident within a few days

Etiology
* Most common is preexisting dermatoses: (53%);
o atopic dermatitis, chronic actinic dermatitis, psoriasis,seborrheic dermatitis, vesicular palmoplantar eczema, pityriasis rubra pilaris, and contact dermatitis
* Drug eruptions(5%);
o allopurinol, gold, carbamazepine, phenytoin, and quinidine
* Cutaneous T-cell lymphoma(13%); Sezary syndrome and mycosis fungoides
* Paraneoplstic (2%); carcinoma of the lung and carcinoma of the stomach
* Leukemia cutis (1%)
* Idiopathic (26%)
* Mortality rate at a mean follow-up interval of 51 months was 43%
Histology
* Most commonly, histology is nonspecific
* Hyperkeratosis & focal parakeratosis
* Epidermis shows mild acanthosis, scant superficial upper dermal infiltrate of mononuclear cells
* May be small areas of spongiosis
* Generalization after withdrawal of methotrexate
* Exfoliation of scale with underlying erythema
* Generalized erythema with thick scale and crusted fissures on the plantar surface
Treatment
* Topical steroids, soaks, and compresses
* Acitretin and cyclosporin-useful in psoriatic erythroderma, and isotretinoin in erythroderma caused by RPR; methotrexate
* Systemic corticosteroids in severe cases
* Discontinuing the offending drug in drug-induced cases
* Subungual hyperkeratosis and distal dystrophy

Parapsoriasis, Pityriasis Rosea, Pityriasis Rubra Pilaris
Parapsoriasis
* Group of macular scaly eruptions with slow evolution
* These are all markedly chronic, resistant to treatment, and are without subjective symptoms
* They are divided into: pityriasis lichenoides chronica, pityriasis lichenoides et varioliformis acuta, and parapsoriasis en plaques

Pityriasis Lichenoides Chronica
* Erythematous, yellowish, scaly macules and lichenoid papules
* They persist indefinitely without change
* Mainly on sides of trunk, thighs, and upper arms
* May be confused with psoriasis and secondary syphilis
* Tx- UV light is beneficial; however intense doses may be needed for good results
* PUVA has been reported to be effective
* Oral tetracycline may be used with antihistamines
* PLC is a benign disease that clears spontaneously in a few yrs to months
PLEVA
* AKA: parasoriasis lichenoides, Habermann’s disease, Mucha-Habermann disease and parapsoriasis varioliformis acuta
* Sudden appearance of a polymorphous eruption composed of macules, papules, and occasional vesicles
* May run an acute, subacute, or chronic course
* Papules are usually yellowish or brownish-red, round lesions, which tend to crust, become necrotic and hemorrhage
* When exanthem heals it leaves a smooth, pigmented, depressed, varioliform scar
* Favorite sites are anterior trunk, flexural arms, and axillae
* Palms and soles are involved infrequently-mucous membranes are not
* Generalized lymphadenopathy can occur
* Usually a benign, self-limited disorder, but may be more chronic and severe
* Maybe a spectrum of cutaneous T-cell lymophoma
* Differential dx:
o leukocytoclastic angiitis, papulonecrotic tuberculid, psoriasis, lichen planus, varicella, PR, drug eruptions, maculopapular syphilid, viral, rickettsial diseases, lymphomatoid papulosis
* Histologically of PLEVA is characterized by epidermal necrosis, with prominent hemorrhage and primarily a dense perivascular infiltrate of lymphocytes in the superficial dermis
* Absence of neutrophils simplifies the distinction between leukocytoclastic angiitis
* Lymphomatoid papulosis differs by the presence of large, atypical mononuclear cells in the dermal infiltrate

PLEVA-Tx
* No one tx is reliably effective
* Tetracycline and erythromycin are worth trying
* UVB and PUVA
* Methotrexate, 2.5-7.5mg every 12 hrs for 3 doses 1 day each week
* Several serious reactions a few of them fatal have occurred with simultaneous administration of methotrexate and NSAIDs
* Dapsone and pentoxifylline(Trental), 400mg twice daily


Parapsoriasis en Plaques
* Small-plaque parapsoriasis is characterized by non-indurated, brownish, hypopigmented, or yellowish red scaling patches, round to oval, with sharply defined borders
Large Plaque Parapsoriasis
* Has patches 5-15 cm; otherwise is similar to small-plaque type
* Prognosis is benign, especially if pruritis is severe
* 10% may eventuate in T-cell lymphoma
* Large plaques parasporiasis: large, variably erythematous and mildly poikilodermatous patches in the bathing trunk region
* Small plaque parasporiasis: small(<5), erythematous, slightly scaly patches
Treatment
* First line: UV radiation -- either natural or UVB
* Lubricants and Topical steroids
* PUVA but only if UVB fails
* Use of PUVA or high-potency topical streroids should be limited due to long-term adverse effects
* LPPP has the potential to develop lymphoma – thus, justifying more intense tx
* Vitamin D2 daily–250,000 units over 2-4 months has been effective

Pityriasis Alba
* AKA-pityriasis streptogenes, furfuraceous impetigo, pityriasis simplex, pityriasis sicca faciei, and erthema streptogenes
* Characterized by hypopigmented, round to oval, scaling patches on face, upper arms, neck, or shoulders
* Color is white (but never actually depigmented) or light pink
* Scales are fine and adherent
* Patches are usually sharply demarcated; edges may be erythematous and slightly elevated
* Lack of any early specifically follicular localization helps to distinguish this lesion from follicular mucinosis
* Vellus hairs are not lost in pityriasis alba, nor does hypesthesia to cold occur, as often happens in follicular mucinosis
* Usually asymptomatic; however there may be mild pruritis
* Disease mainly occurs in children and teenagers
* It is particularly a cosmetic problem in dark-skinned individuals
* Etiology unknown
* Excessively dry skin appears to be contributory
* Most lesions disappear with time
* Repigmentation can be accelerated with treatment
* Emollients and bland lubricants
* Low-strength corticosteroids plus Lac-Hydrin are helpful
* Others have recommended PUVA

Pityriasis Rosea
* Mild inflammatory exanthem of unknown origin ?viral
* Characterized by salmon-colored papules and patches which are oval and covered with a collarette of scale
* Disease frequently begins with a single herald patch, which may persist a week or more, then involutes
* Appears rapidly and last from 3-8 weeks
* Peak: ages 15-40
* Typically in Spring and Autumn
* More common in women
* Mainly affects the trunk
* Oral lesions are relatively uncommon, but present as aphthous lesions

Herald Patch
Pityriasis Rosea
* Papular PR is an unusual form common in black chidren under age 5
* Inverse PR is unusual, but not rare
* Relapses and recurrences are frequently observed
* A PR-like eruption can occur as a rxn to captopril, arsenicals, gold, bismuth, clonidine, methoxypromazine, tripelennaminehydrochloride, or barbituates
* Inverse pityriasis rosea: oval annular plaques in groin

Treatment
* Supportive
* UVB should be used after acute inflammatory stage has passed
* Topical corticosteroids
* Antihistamines
* Emollients
* PR: There is focal parakeratosis, mild acanthosis, spongiosis, perivascular lymphocytes, and focal erythrocyte extravasation
* PR: papules and annular plaques
* PR: oval and round plaques, some with central scale and others with a collarette of scale
* PR in darkly pigmented skin: it tends to be more papular than in lightly pigmented skin-note associated hyperpigmentation

Pityriasis Rubra Pilaris
* Chronic skin disease characterized by small follicular papules, disseminated yellowish pink scaling patches, and often, solid confluent palmoplantar hyperkeratosis
* Disease generally manifests itself first by scaliness and erythema of the scalp

PRP
* Involvement is usually symmetrical and diffuse, with islands of normal
* Hyperkeratosis of palms and soles called, the “sandal”
* Nails may be dull, rough, thick, and brittle
* Itching in some cases
* Koebner’s phenomenon may be present
* A number of cases have been associated with Kaposi’s sarcoma, leukemia, basal cell, lung, unknown primary metastatic and hepatocellular carcinoma
* PRP may classified into familal or acquired types

in respect to the onset of the disease in childhood or adulthood

* Griffth’s classification: Type I, the classic adult type, is seen most commonly, with 80% involuting in 3 years
* Three types of juvenile-onset forms account for up to 40% of cases and have a poor prognosis for involution
* Etiology unknown-??AD
* Either sex affected
* Possible related to deficiency of

vitamin A
* Histology: hyperkeratosis, follicular plugging, and focal parakeratosis at follicular orifice
* Inflammatory infiltrate in dermis is composed of mononuclear cells
* PRP: psoriasiform dermatitis with follicular plugging
Treatment
* Symptomatic: emollients-- Lac-Hydrin
* A several-month course of isotretinoin in doses of 0.5 – 2 mg/kg/day
* Vitamin A in doses of 300,00 to 500,000 untis daily, with possible addtion of vitamin E, 400 units 2-3 times daily
* Methotrexate 2.5mg alternating with 5mg daily
* Monitor and treat secondary infections
* Pityriasis rubra pilaris: diffuse erythroderma with desquamation and follicular hyperkeratosis
* Pityriasis rubra pilaris: follicular papules and confluent orange-red scaly plaques with islands of sparing
* Pityriasis rubra pilaris: orange-red waxy keratoderma of the palms

Andrews’ Diseases of the Skin.ppt

Read more...

Cutaneous Vascular Diseases



Cutaneous Vascular Diseases
by:Rick Lin, DO MPH
KCOM Dermatology Residency Program

Raynaud’s Phenomenon
* Intermittent constriction of the small digital arteries and arterioles
* Persistently cyanotic and painful
* Aggrevated by cold weather
* Young middle aged women
* Assoc c scleroderma, dermatomyositis, LE, Mixed connective tissue diseases, Sjogren’s RA, and paroxysmal hemoglobinuria.
* Scleroderma is the underlying condition for more than half of the patients
* Maybe caused by medications, ie bleomycin

The LDI images below graphically illustrate the vasospasm of Raynaud’s phenomenon following a cold provocation.

Raynaud’s Disease
* Primary disorders
* Pallor, cyanosis, hyperemia, and numbness of the finger
* Precipitated by cold.
* Present for 2 years with out associated disease finding
* Good prognosis
* Multifactorial.
* Increase alpha-2 sympathetic receptor activity on vessels.
* Endothelia dysfunction
* Deficiency in calcitonin gene related protein
* Central thermoregulatory defects
* Treatment include avoidance of aggravating factor, ie cold.
* Vasodilating drugs, nifedipine, 10-20 mg tid; prazosin 1-3 mg tid
* Nitroglycerin 2% local application

Erythromelalgia
* Aka erythermalgia and acromelalgia
* May be secondary to myeloproliferative disease such as polycythemia vera, TTP
* Responds to treatment of primary disorders
* Cold water immersion

Livedo Reticularis
* Mottled or reticulated pink/reddish/blue discoloration
* Assoc c LE, DM, scleroderma, RA
* Side effect of amantadine

Necrotizing livedo reticularis
* Assoc c nodules and ulcerations
* Result from sever atherosclerotic disease
* Sneddon’s syndrome

Livedoid Vasculitis
* atrophie blanche
o White stellate scars of ulcers
* PURPLE (Painful purpuric ulcer with reticular pattern of the lower extremity)
* Histologically shows chronic perivascular hemorrhage.

Treatment
* Low Dosage of Aspirin 325mg qd
* Nifedipine 10mg TID
* Pentoxifylline 400mg BID-TID

Marshall-White Syndrome
* Bier’s Spot: White spot appear on hand with blood pressure cuff
* Consist of Bier’s spot and is associated with insomnia and tachycardia
* White middle age men

Purpura
* Multifocal extravasation of blood into the skin
* Petechiae <3mm
* Ecchymosis
* Vobices (vibex) – Linear
* Hematoma – pool-like collection
* Complete blood count
* PT and PTT

Thrombocytopenic Purpura
* Three Large Categories:
o Accelerated platelet destruction
o Deficient platelet production
o Unknown pathogenesis

Idiopathic Thrombocytopenic Purpura
* Aka autoimmune thrombocytopenic purpura
* Aka Werlhof’s disease
* Bleeding occurs when platelet count drops below 50,000
* Risk greatly increased for serious hemorrhage when count goes below 10,000
* Acute variety occurs in children following season viral illness in 50% of the patient.
* Lag between illness and onset of purpura is 2 weeks
* Resolve spontaneously with minimal therapy
* Chronic case may result in death.
* Chronic form most often occur in adult
* Evaluate patient with Tc99M radionuclide scan to look for accessory spleen
* Result of platelet injury by antibodies of IgG class
* Treatment include Splenectomy, systemic corticosteroid, IVIg

These are the kidneys from a case of idiopathic thrombocytopenic purpura. Petechiae are found throughout the renal parenchyma.

Drug-Induced Thrombocytopenia
* Drug induced antiplatelet antibodies
* May be caused by sulfonamides, digoxin, quinine, quinidine, PCN, furosemide, Lidocaine, methyldopa

Thrombotic Thrombocytopenic Purpura
* Aka Moschcowitz syndrome
* Pentad of thrombocytopenia, hemolytic anemia, renal abnormalities, fever, CNS disturbance.
* Delay in diagnosis may lead to a mortality rate as high as 90%
* Positive histologic diagnosis require gingival biopsies looking for subendothelial hyaline deposits
* Exchange plasmapheresis is required for treatment. 80% patient survive if treatment is instituted.

Dysproteinemic Purpura
* Aka Nonthrombocytopenic purpura
* Aka purpura cryoglobulinemica
* Aka cryofibrinogenemia
* Occur most frequently in multiple myeloma and macroglobulinemia of monoclonal IgM, IgG, or Bence Jones cryoglobulin.
* Tx with plasmaphoresis, systemic steroid, and immunosuppressors.

Purpura Hyperglobulinemica
* Aka Waldenstrom’s hyperglobulinemic purpura
* Consist of episodic showers of petechiae occuring on all parts of body
* Diffuse peppery distribution, resembling Schamberg’s
* Most useful labtest is protein electrophoresis
* Hyperglobulinemic purpura occurs most commonly in women.
* Frequently seen with Hepatitis C and Sjogren’s syndrome, keratoconjunctivitis sicca, RA
* Histologically: derma vessels with perivascular infiltrate of mononuclear cells.
* Benign and chronic course. Assoc c various of connective tissue diseases.

Waldenstrom’s Macroglobulinemia
* Bleeding from mucous membrane of the mouth and nose, lymphadenopathy, hepatomegaly, retina hemorrhage, and RARELY the purpura
* Perivasular infiltrate containing lymphocytes and neutrophils and eosinophils
* Plasmaphoresis until adequate dose of chlorambucil is administered. Cyclophosphamide and corticosteriods are treatment options as well

A Skull X Ray showed a single, small, left-sided lytic Defect.
Drug- and Food Induced Purpura
* Drug induced purpura may occurs without platelet destruction.
* Cocaine induced thrombosis with infarct skin assoc c skin popping.
* Rumpel-Leede sign: distal shower of petechiae that occurs immediately after the release of pressure from a tourniqut release. Associated with capillary fragility.
* Topical EMLA can induce purpura in 30m.
Solar Purpura
* Large, sharply outlined 1-5 cm dark purplish red ecchymoses on dormsum of the forearm
* Less frequently, back of the hand

Purpura Fulminans
* Aka purpura gangrenosa
* Severe, rapidly fatal reaction occurring most commonly in children after infectious illness
* May follows scarlet fever, strep pharyngitis, and meningococcal meningitis.
* Assoc c Protein C or S deficiency in Neonates
* Management is supportive
* Protein C replacement if protein C deficiency is present
* Fresh frozen plasma maybe useful

Disseminated Intravascular Coagulation
* Up to 2/3 of DIC patients have skin lesions
* Minute, widspread petechiae, ecchymoses, ischemic necrosis of the skin and hemorrhage bullae.
* Elevated PT and PTT, fibrin degradation products
* Decrease platelets, decreased fibrinogen

Disseminated Intravascular Coagulation
* All patient needs to receive vitamin K replacement to exclude vitamin K deficiency.

Fibrinolysis Syndrome
* An acute hemorrhagic state brought by inability of the blood to clot
* Massive hemorrhages into the skin produce blackish, purplish swelling.
* Can be a complication of pregnancy in cases of placental previa, eclampsia, and fatal death
* Excessive fibrinolysis

Blue Muffin Baby
* Purpuric lesions observed in newborns with congenital rubella
* Assoc c disease that produce extramedullary erythropoesis
* Generalized dark blue to magenta nonblanchable, indurated, round, oval hemispheric papules 1-7mm
* Evaluation c biopsy, TORCH serology, CBC, viral culture.
Itching Purpura

* Aka diseminated pruriginous angiodermatitis
* Orange-purpleish-red petechiae evolve completely and may become confluent in 2 weeks
* Runs its course in 3-6 months. May become chronic
* Unknown etiology

Deep Vein Thrombosis
* Almost always affect femoral vein
* Leads to Reversible ischemia or frank gangrene
* Significant superficial vein thrombosis is a risk factor for DVT
* Pulmonary Embolism is a major concern
* Malignant Neoplasms are the most common underlying condition
* Pulmonary Embolism has 40% mortality
* DVT is assoc c 35% of cancer associated causes as the first sign
* Patient younger than 40 with DVT prompt for search for cancer

Superficial Thrombophlebitis
* Painful induration with erythema
* Linear or branching configuration forming cords
* Assoc c hypercoagulable state
* Need to be evaluated for possibility of deep veous disease

Mondor’s Disease
* 3:1 = women:men
* Age range 30-60
* Sudden appearance of a cord like thrombosed vein along the anterior-lateral chest wall
* First red and tender and subsequently change into a painless tough, fibrous band.
* No systemic symptom associated
* Treatment of the symptom: hot moist dressing with NSAID
* Runs its course for 3-6 months.

Calciphylaxis
* End-stage renal disease patients with metastatic calcification are most exclusively affected by this disease.
* Reticulated violaceous, mottled patches
* Progress into ecchymosis, central necrosis, and ulceration
* 50%+ morbidity and mortality
* Death is usually caused by staphylococcal sepsis after infection
* Hyperbaric oxygen has used with some success

* On low magnification, basophilic alteration of a fibrous septum can be seen Fibrin thrombi are also present within many of the blood vessels of the subcutaneous adipose tissue (Figure 3). Higher magnification identifies calcium deposition within the fibrous septum, primarily on elastic fibers (Figure 4, Figure 5). Higher magnification of the same area with Verhoeff-van Gieson stain confirms the presence of fragmented elastic fibers (Figure 6). Special stain for calcium (von-Kossa) identifies calcium deposition both within the septum of the fat lobule (Figure 7) and within the walls of blood vessels (Figure 8).
Fibrin thrombi are also present within many of the blood vessels of the subcutaneous adipose tissue

Higher magnification of the same area with Verhoeff-van Gieson stain confirms the presence of fragmented elastic fibers

Special stain for calcium (von-Kossa) identifies calcium deposition both within the septum of the fat lobule

Scorbutic Purpura
* Bleeding gums
* Deficiency in Vitamin C
Achenbach’s Syndrome
* Aka Paroxysmal Hand Hematoma
* Spontaneous focal hemrhage into palm or volar suface
* Transitory localized pain followed by rapid swelling and bluish discoloration
* Acute nature with rapid resolution

Painful Bruising Syndrome
* Aka Autoerythrocyte Sensitization
* Aka Gardner-Diamond Syndrome
* Distinctive localized purpuric reaction
* Young and middle-aged women with some emotional disturbance
* Emotional upset is the precipitating factor
* Intracutaneous injections of erythrocytes stroma evoke lesions
* Some believe the symptome to be artifactual.

Psychogenic Purpura
* Similar purpura as Painful bruising syndrome
* Absence of erythrocytes sensitivity
* Secretan’s syndrome: factitial lymphedema of the hand
* L’oedeme bleu: factitial lymphadema of the arm

Pigmentary Purpuric Eruption
* Pigmented purpuric eruptions of the lower extremities
* Similar histologic finding
* Shamberg’s
* Majocci’s
* Gougerot-Blum

Shamberg Diseases
* Aka progressive pigmentary dermatosis
* Grains of cayenne pepper
* Lesions seldom itch
* Favors lower shins and ankles

Majocchi’s Disease
* Aka purpura annularis telangiectodes
* Bluish annular macules 1-3cm in diameter with telangiectatic puncta
* Begins symmetrically at lower extremities
* Involution requires as long as a year, and may prolong indefinitely
* Asymptomatic.
Gougerot-Blum
* Pigmented purpuric lichenoid dermatitis
* Minute, rust-colored lichenoid papules that fuse into plaques of various hues
* Legs, thighs, and lower trunk
* Differentiate from Schamberg based on distribution and lichenoid lesions.
* Lichen Aureus

Ducas Kapetanakis pigmented purpura
* Histologically present with distinguished from others by presence of spongiosis
* Must be distinguished from mycosis fungoides
Histology

* Purupra Majocchi-Schamberg is characterized by slight alteration of superficial capillaries with hemorrhage and perivascular lymphocytic infiltrate.

Cutaneous Vascular Diseases Part-1.ppt
Cutaneous Vascular Diseases Part-2.ppt

Read more...

Syphilis



Syphilis
by: Erik Austin, D.O., M.P.H.

Syphilis
* AKA lues
* Contagious, sexually transmitted disease caused by the
* Spirochete: Treponema pallidum
* Enters through skin or mucous membrane where primary manifestations are seen

Treponema pallidum
* Spiral spirochete that is mobile
* # of spirals varies from 4 to 14
* Length is 5 to 20 microns
* Can be seen on fresh primary or secondary lesions by darkfield microscopy or fluorescent antibody techniques

Syphilis epidemiology
* Major health problem throughout world
* 2.6 cases per 100,000 in 1999 in the US
* Lowest level ever recorded
* Concentrated in 28 counties in the SE U.S.
* Mainly gay men and crack cocaine users
* Enhances risk of transmission of HIV
* HIV testing recommended in all patients with syphilis
* Reportable disease

Serologic Tests
* Testing reveals patients immune status not whether they are currently infected
* Non-treponemal antigen test uses lipoidal antigens rather than T. pallidum or components of it
* RPR = rapid plasma reagin
* VDRL = Venereal Disease Research Laboratory
* Positive within 5 to 6 weeks after infection
* Strongly positive in secondary phase
* Strength of reaction is stated in dilutions
* May become negative with treatment or over decades
* MHA-TP: microhemagglutination assay for T. pallidum
* FTA-ABS: fluorescent treponemal antibody absorption test
* All positive nontreponemal test results should be confirmed with a specific treponemal test
* Treponemal tests become positive early, useful in confirming primary syphilis
* Remain positive for life, useful in diagnosing late disease
* Treatment results in loss of positivity in 13-24% of patients

Biologic False-Positive Test Results
* Positive test with no history or clinical evidence of syphilis
* Acute BFP: those that revert to negative in less than 6 months
* Chronic BFP: those that persist > 6 months

BFP Test Results in Syphilis
* Acute BFP
* Vaccinations
* Infections
* pregnancy
* Chronic BFP
* Connective tissue disease (SLE)
* Liver disease
* Blood transfusions
* IVDA

Cutaneous Syphilis
* Chancre is usually the first cutaneous lesion
* 18 to 21 days after infection
* Round indurated papule with an eroded surface that exudes a serous fluid
* Usually painless and heals without scarring

Chancre
* Inguinal adenopathy 1-2 weeks after chancre
* Generally occur singly, but may be multiple
* Diameter mm to cm

Chancres
* In women, the genital chancre is less often observed due to location within the vagina and cervix
* Edema of labia may occur
* Untreated, the chancre heals spontaneously in 1 to 4 months
* Constitutional symptoms begin just as chancres disappear
* Extragenital chancre: may be larger, frequently on lips, rarely tongue, tonsil, breast, finger, anus.

Chancre Histology
* Ulcer covered by neutrophils and fibrin
* Dense infiltrate of lymphocytes and and plasma cells
* Spirochetes seen with with silver stains; Warthin-Starry
* Direct fluorescent antibody tissue test (DFAT-TP) = serous exudate collected on a slide sent for exam

Serology
* Nontreponemal tests positive 50%
* Treponemal tests positive 90%
* Positivity depends upon duration of infection, if chancre has been present for several weeks, test is usually positive

Chancre vs. Chancroid
* Incubation 3 weeks
* Painless
* Hard
* Lymphadenopathy may be bilateral, nontender, nonsuppurative
* Incubation 4-7 days
* Painful
* Soft
* Lymphadenopathy unilateral, tender, suppurative

DDx in Syphilis
* Chancroid - multiple lesions, may coexist with chancre, must r/o syphilis
* Granuloma Inguinale - indurated nodule that erodes, soft red granulation tissue, Donovan bodies in macrophages with Wright or Giemsa stain
* Lymphogranuloma Venereum - small, painless, superficial non indurated ulcer, primary lesions followed in 7 to 30 days by adenopathy
* HSV - grouped vesicles, burning pain

Secondary Syphilis
* Skin manifestations in 80% called syphilids
* Symmetric, generalized, superficial, macular - later papular, pustular
* May affect face, shoulders, flanks, palms and soles, anal or genital areas

Secondary Syphilis Macular Eruptions
* Exanthematic erythema 6-8 weeks after chancre - may last hours to months
* Round, slightly scaly ham-colored macules
* Pain and pruritus may be present
* Generalized adenopathy

Secondary Syphilis Papular Eruptions
* Occurs on face and flexures of arms, legs, and trunk
* Yellowish-red spots may appear on palmar and plantar surfaces
* Ollendorf’s sign = tender papule
* May produce a psoriasiform eruption
* May appear as minute scale-capped papules
* Tend to be disseminated, but may be localized, asymmetrical, configurate, hypertrophic or confluent.
* Annular syphilid - mimics sarcoidosis and is more common in blacks
* Pustular syphilid – rare - face, trunk, extremities red small crust-covered ulceration
* Rupial syphilid - superficial ulceration is covered with a pile of terraced crusts resembling an oyster shell.
* Lues Maligna - rare, severe ulcerations, pustules, or rupioid lesions, accompanied by severe constitutional symptoms.
* Condylomata lata - papular mass, weeping, gray 1-3cm, groin, anus (not vegetative like condylomata acuminata)
* Syphilitic alopecia - irregular, scalp has a moth-eaten appearance 5% of pts

Secondary Syphilis Mucous Membrane
* Present in 1/3 of secondary syphilis
* Most common is “syphilitic sore throat”
* Diffuse pharyngitis, hoarseness
* Tongue may show patches of desquamation of papillae
* Ulcerations of tongue and lips in late stages
* Mucous patches are the most characteristic mucous membrane lesions; macerated, flat. Grayish, rounded erosions covered by a delicate, soggy membrane.

Secondary Syphilis Systemic Involvement
* Lymphadenopathy common.
* Acute glomerulonephritis, gastritis, proctitis, hepatitis, meningitis, iritis, uveitis, optic neuritis, Bell’s palsy, pulmonary nodular infiltrates, osteomyelitis, polyarthritis.

Secondary Syphilis Diagnosis
* Nontreponemal serologic tests for syphilis are strongly reactive (seronegativity rarely in AIDS)
* Spirochetes on darkfield exam

Secondary Syphilis DDx “Great Imitator”
* Pityriasis rosea
* Drug eruptions (pruritic)
* Lichen planus; Wickham’s striae, Koebner’s, pruritic
* Psoriasis; no adenopathy
* Sarcoidosis; need serology and silver staining of biopsy
* Infectious mononucleosis, false pos RPR
* Geographic tongue
* Aphthous stomatitis

Latent Syphilis
* After the lesions of secondary syphilis have involuted, a latent period occurs where the patient has no clinical signs, but positive serological tests
* May last a few months or a lifetime
* 60-70% of pts that are untreated remain asymptomatic for life
* Women may infect unborn child for 2 years
Late Syphilis
* Defined by CDC as infection of greater than 1 years duration
* Tertiary Cutaneous Syphilis
* Late Osseous Syphilis
* Neurosyphilis
* Late Cardiovascular Syphilis

Tertiary Cutaneous Syphilis
* Tertiary syphilids usually occur 3-5 years after infection
* 16% of untreated pts will develop lesions of skin, mucous membrane, bone or joints
* Skin lesions are localized, destructive, heal with scarring

Tertiary Syphilids
* Two main types; Nodular syphilid and the Gumma
* Nodular - reddish brown firm papules or nodules 2mm or larger, scales.
* Gumma - larger

Nodular Tertiary Syphilid
* Lesions tend to form rings and undergo involution as new lesions develop
* Characteristic circular or serpiginous pattern
* “kidney-shaped” lesion occurs on the extensor surfaces of the arms and on back
* Patches have scars and fresh ulcerated lesions
* Process may last for years, slowly marching across large areas of skin

Gumma
* May occur as unilateral, isolated, single or disseminated lesions, or serpiginous
* May be restricted to the skin, or originate in deeper tissues, and break down the skin
* Lesions begin as small nodules, enlarge to several centimeters
* Central necrosis, deep ulcer with a gummy base, most frequent site is lower legs

Diagnosis of Tertiary Syphilis
* Histopathology - tuberculoid granules with multinucleated giant cells
* Nontreponemal tests (VDRL, RPR) positive in 75%
* Treponemal tests (FTA-ABS, MHA-TP, TPI) positive in nearly 100%
* Darkfield negative, PCR may be positive

DDx Tertiary Syphilis
* R/O tumors; SCCA tongue, leukemic infiltrates, sarcoidosis
* Ulcerated syphilids resemble scrofula, atypical mycobacterium, sporotrichosis, blastomycosis
* Mycosis fungoides (CTCL) has eczema and pruritus
* Perforation of hard palate and septum

Late Osseous Syphilis
* Gummatous lesions can involve the periosteum and bone
* Head, face, tibia
* Periostitis, osteomyelitis, osteitis, gummatous osteoarthritis
* “Osteocope” - bone pain often at night
* Charcot joint - loss of contours of joint, hypermobility, painless
* Associated with tabes dorsalis

Neurosyphilis
* CNS involvement with syphilis can occur at any stage
* Most are asymptomatic; CSF shows pleocytosis
* 4-10% of untreated pts will develop neurosyphilis

Early Neurosyphilis
* First year of infection - meningeal
* Headache, stiff neck, cranial nerve disorders, seizures, delirium, increased ICP

Meningovascular Neurosyphilis
* 4-7 years after infection
* Thrombosis of vessels in the CNS
* Hemiplegia, aphasia, hemianopsia, transverse myelitis, progressive muscular atrophy
* CN palsies; CN IIX, III, IV, VI
* “Argyll Robertson Pupil” accommodates, but doesn’t react

Late Neurosyphilis
* Parenchymatous neurosyphilis occurs more than 10 years after infection
* Two classical patterns; Tabes Dorsalis, and General Paresis

Tabes Dorsalis
* Degeneration of the dorsal roots of the spinal nerves and posterior columns of the the spinal cord
* Gastric crisis with severe pain and vomiting is most common
* Pain, urination problems, paresthesias, ataxia, diplopia, vertigo, deafness
* Signs: Argyll Robertson pupil, reduced lower cord reflexes, Romberg sign, sensory loss, atonic bladder, Charcot’s joints, optic atrophy
* Personality changes, memory loss, apathy, megalomania, delusions, dementia

Late Cardiovascular Syphilis
* Occurs in 10% of untreated pts
* Aortitis, aortic insufficiency, coronary disease, aortic aneurysm

Congenital Syphilis
* Prenatal syphilis acquired in utero
* Infection through the placenta usually does not occur before the fourth month, so treatment of the mother before this time will almost always prevent infection in the fetus.
* If infection occurs after the fourth month 40% risk of fetal death

* 40% of pregnancies in women with untreated early syphilis will result in a syphilitic infant.
* Most neonates with congenital syphilis are normal at birth.
* Early congenital syphilis - lesions occurring within first two years of life
* Late congenital syphilis - lesion occur after two years

Early Congenital Syphilis
* Cutaneous manifestations appear most commonly during 3rd week
* Snuffles (a form of Rhinitis) is most frequent, bloody drainage, ulcers may develop, later septal perfs
* 30-60% of infants develop cutaneous lesions similar to secondary syphilis
* Red to copper maculopapular, become large, scaling, pustules, crusting
* Face, arms, buttocks, legs, palms and soles

Early Congenital Syphilis
* Face, perineum, and intertriginous areas, usually fissured lesions resembling mucous patches. Radial scarring results leading to Rhagades
* Bone lesions occur in 70-80% , epiphysitis is common and causes pain on motion, leading to infant refusing to move; Parrot’s pseudoparalysis.
* Radiologic features of the bone lesions in congenital syphilis during the first 6 months are characteristic.
* Bone lesions occur at the epiphyseal ends of long bones.
* Lymphadenopathy, hepatomegaly, nephrotic syndrome, meningitis, nerve palsies may all occur

Late Congenital Syphilis
* Lesions are two types - malformations of tissue affected at critical growth periods (Stigmata) and persistent inflammatory foci
* Inflammatory - lesions of the cornea, bones, and central nervous system, i.e., interstitial keratitis in 20-50%, perisynovitis of knees (Clutton’s joints), tabes dorsalis, seizures, and paresis

Late Congenital Syphilis
* Malformations (Stigmata) - destructive effects leave scars or developmental defects
* Hutchinson’s Triad - Changes in incisors, corneal scars, and eighth nerve deafness
* Also, saber shins, rhagades of the lips, saddle nose, mulberry molars

Hutchinson’s Teeth
* Malformation of the central upper incisors that appears in the second or permanent teeth. Teeth are cylindrical rather than flattened, cutting edge narrower than base, notch may develop
* Mulberry molar - first molar hyperplastic, flat occlusal surface covered with knobs representing abortive cusps

Treatment of Syphilis
* PCN is drug of choice for treatment of all stages of syphilis.
* HIV testing is recommended in all patients
* If less than one year; 2.4M U of Benzathine PCN G
* PCN-allergic; Tetracycline 500mg QID for 14 days

Jarisch- Herxheimer Reaction
* Febrile reaction occurs after the initial dose of antisyphilitic tx, 60-90% of pts
* 6-8 hours after dose - chills, fever, myalgia, increase in inflammation (neurosyphilis)

Treatment of Sex Partners
* Persons exposed to a patient with early syphilis within the previous 3 months should be treated, even if seronegative
* Single dose azithromycin effective in treating incubating syphilis

Serologic Testing after Tx
* VDRL or RPR repeated every 3 months in first year, every 6 months in second year, than annually
* A fourfold decrease in titer should be seen at 6 months, if not then 3 weekly PCN IM injections
* Response for latent syphilis is slower, 12-24 months
* If not responding; HIV and CSF testing repeated
* Pts with late syphilis may be “serofast”, and titers may not improve
* Neurosyphilis pts should have CSF every 6 months

Syphilis and HIV
* Most HIV pts exhibit the classic clinical manifestations and course, and respond similarly to tx
* More likely to present with secondary syphilis and have a persistent chancre

Yaws
* Treponema pallidum subsp. Pertenue
* Endemic in some tropical, rural regions
* Overcrowding, poor hygiene, transmitted by contact with infected lesions
* Children, disabling course, affects skin, bones, and joints

Early Yaws
* Primary papule or group of papules appear at site of inoculation after 3 week incubation period, initial lesion becomes larger and crusted (Mother Yaw, maman pian )
* Feet, legs, buttocks, face, not genitals
* Mother yaw disappears after a few months
* Secondary Yaws – appears weeks or months after mother yaw appears. May be smaller and appear around primary lesion; may be annular (ringworm yaws)
* Condylomata may develop around body orifices and creases
* Palms and soles may form hyperkeratotic plaques leading to a painful crab-like gait (crab yaws)

Late Yaws
* 10% progress to late stage where gummas occur
* Ulcer with clean edges that tend to fuse to form con figurate and serpiginous patterns similar to tertiary syphilis
* Bone, joint, saddle nose, saber shin, Gangosa (destruction of palate and nose)
* Diagnosis = Darkfield, VDRL or RPR

Endemic Syphilis (Bejel)
* Bejel is a Bedouin term for nonvenereal treponematosis, nomadic tribes of North Africa, Southwest Asia, Eastern Mediterranean
* T. pallidum subsp. Endemicum
* Usually occurs in childhood through skin contact
* May affect the skin, oral mucosa, and skeletal system

Bejel
* Primary lesions rare, probably go undetected in the oral mucosa
* Secondary oral lesions - shallow, painless ulcers, laryngitis
* Condyloma of axillae and groin, lymphadenopathy, osteoperiostitis causes night leg pain
* Untreated secondary bejel heals in 6-9 months
* Tertiary stage - gummatous ulcerations of the skin, nasopharynx, and bone.
* Neuro - uveitis, choritis, optic atrophy

Pinta
* T. carateum; nonvenereal, endemic
* Only skin lesions occur
* All ages, Brazilian rain forest
* Primary Stage - 7 to 60 days after inoculation. Lesion begins as a tiny red papules and become an elevated erythematous infiltrated plaque 10cm in diameter over 2-3 months. Legs -satellite lesions, no erosion or ulceration as in chancres.
* Secondary Stage - 5 months to 1 year
* Small, scaling papules that enlarge and coalesce – affects extremities and face
* Red to blue, black with postinflammatory hyperpigmentation
* Nontreponemal tests reactive in 60%
* Late Dyschromic Stage - young adults – may appear as hyperpigmented and depigmented macules resembling vitiligo
* Face, waist, wrist, trochanteric areas
* Histo - acanthosis, lichenoid, spirochetes in epidermis

Treatment of Yaws, Bejel, and Pinta
* Benzathine PCN G 1.2 to 2.4 M units IM
* Tetracycline 500mg QID for adults
* EES 10mg/kg children QID for 14 days
Nonvenereal Treponematoses
* Yaws
* Endemic Syphilis
* Pinta

Treatment
* Syphilis >1year; 2.4M PCN G weekly for 3 weeks Pcn-allergic; Tetra 500mg QID for 30 days
* Neurosyphilis; IV
* Infant 100,000 to 150,000 units/kg/day Procaine PCN BID for first seven days of life

Syphilis.ppt

Read more...

28 September 2009

Common Foot & Ankle Problems



Common Foot & Ankle Problems

Hallux Valgus / Bunion Deformity
* A structural (bony) deformity where the metatarsal bones spread apart causing a prominent bone to protrude on the inside of the foot.
* A progressive deformity.
* May be treated conservatively, but usually requires surgical correction if pain persists.

Bunion prior to correction
Bunion after correction
Severe Hallux Valgus / Bunion Deformity
Cut in bone and fixation with screws

Tailor’s Bunion / Bunionette
* Bony deformity which is located on the outside part of the foot.
* The bump, bunionette or Tailor’s Bunion, can become very painful due to shoe irritation.
* Tailor’s bunions may be treated conservatively. Surgical correction may be necessary.

Note prominent 5th metatarsal head with swelling
Note Bowing of the Metatarsal
Note Straight Metatarsal
After Correction
Prior to Correction
Tailor’s Bunion / Bunionette
Hammertoe Deformity
* Contracted or abnormal position of the toes, which may be flexible or rigid in nature.
* Usually caused by weakened muscles of the foot.
* May cause pain due to irritation from other toes. The pain may be exasperated by tight fitting shoes.
* Hammertoes are often accompanied by a corn or callous.
Toe prior to surgery
Toe after surgery
Hammertoe Deformity
Hallux Rigidus
* Osteoarthritis of the big toe joint usually associated with pain and restricted motion.
* May be caused by injury or repetitive joint damage due to a biomechanical / structural problem of the foot.
* Chronic wear and tear causes a wearing out of the cartilage at the joint and bone spurs to form.
Hallux Rigidus of the Big Toe Joint
Note bone spur formation

Hallux Rigidus of the Big Toe Joint
Note joint space narrowing and bone spur formation at the joint margins
Rheumatoid Arthritis
* An inherited arthritis which affects joints in the feet and hands.
* The joint destruction and deformities are progressive in nature.
* May predispose patients to bunion and hammertoe formation.
Bunion Deformity
Hammertoe Deformities
Rheumatoid Arthritis
Rheumatoid nodule
Plantar Wart
* Human papaloma virus infection in the feet.
* Warts are obtained by barefoot exposure to the virus.
* Warts are often spread in showers, gyms, or other areas where barefoot walking is common.
* May be treated with any number of methods but recurrence ranges between 18-22%.
Plantar Wart
Callous / Corn
* Thickened area of skin caused by chronic rubbing or irritation of a bony prominence by the ground or shoe gear.
* Very high areas of pressure within a callous can develop a painful central core.
* Lesions reoccur because the cause of the lesion is often from bone.
Callous / Corn
Athletes Foot
* A fungal infection typically caused by fungus found in soil (Dermatophyte).
* Picked up by contact with the fungus usually walking barefoot (Gym, hotel, pool, etc.).
* May occur anywhere on the foot and may burn and/or itch.
* The affected areas of skin will often peel or may have small blisters.
Ingrown Nails
* Toenail which grows into the skin. Most often caused by a wide toenail and an external pressure.
* The nail may cause pain or infection due the pressure of the nail border.
* May be treated with removal and/or antibiotics. May be permanently corrected with retaining a normal nail appearance.
Fungal Toenail
* A thickened nail caused by a fungus.
* Initially caused by an injury to the nail which allows the organism to enter the nail.
* Progressive in nature and slow growing.
* May spread to other nails or other people in close contact. Organism may also spread from nail to the skin (athletes foot).
* May be treated if pain or concerns arise.
Fungal Toenail
Fungal Infection which caused ingrown nail
Thickened curled nails caused by fungus
Nail Injury
* Chronic injury (i.e. athletic activities) causes injury to the nail root and results in nail horizontal layers.
* Isolated injury may also cause bleeding under the nail, leaving a dark spot which persists until the nail grows out.
Lines of injury
Dried blood under the nail plate from injury.
Eczema
Gout
Redness and swelling of the big toe joint
High Arched Feet / Pes Cavus
Pes Cavus / High Arch Feet
Flat Feet
Note low medial arch height
Pes Planus / Flat Feet
Note collapse of entire foot inward
Note low medial arch height
Plantar Fascitis / Heel Spur Syndrome
* Inflammation and partial tearing of a ligament band which attaches from the heel to the ball of the foot.
* Usually a result of poor arch support and overuse.
* May be accompanied by a calcified spur on the heel.
* Usually resolves with conservative treatments.
Ankle Sprain
* Tear or stretching of the ligaments of the ankle. Usually the ligaments on the outside of the ankle are involved.
* Caused by and twisting injury of the foot / ankle .
* Instability of the ankle can develop due to the ligament injury.
* Most often treated conservatively. Surgical repair can be performed to treat chronic ankle sprains.
Bruising after ankle sprain
Morton’s Neuroma
* Injured or compressed nerve most often between the 3rd and 4th toes.
* Burning / pain on the ball of the foot or toes.
* Patients may feel fullness or a mass in the area when they walk.
* Treatments may be conservative or surgical.
Haglund’s Deformity / Retrocalcaneal Exostosis
* Prominent bone on the back of the heel.
* Back of the heel is irritated by shoes and activity, which places pressure on the area.
* Can also be aggravated by a tight Achilles tendon over prominent heel bone.
* Treatments may be conservative or surgical.
Ulcerations
* Erosions of the skin caused by loss of sensation or poor circulation.
* Skin break down occurs which, places patients at risk for local or systemic infection.
Ischemic Ulceration(Ulcer due to poor circulation)
Diabetic Ulceration
Ganglion Cyst
* Benign soft tissue mass which arises from a weak area in a tendon lining or joint.
* Cyst is often filled with a gelatinous fluid.
* Cyst may change size depending on irritation.
Subungual Exostosis
* Bone and cartilage growth under the great toe nail.
* Pain may arise if pressure is placed over the area.
* May be treated with shoe style changes, nail removal or surgical removal.
Venous Stasis
* Discoloration of skin due to longstanding swelling of legs.
* Persistent swelling can lead to skin breakdown.
* Compression and elevation of the legs are essential to the prevention of complications.
Heel Fissuring / Cracking
Heel Fissuring with Hyperkeratosis
Fractured Proximal Phalanx (Toe)
Fractures
Hyperhydrosis
Achilles Tendonitis
Inflammation of tendon

Common Foot & Ankle Problems.ppt

Read more...

Work Related Musculoskeletal Disorders



Work Related Musculoskeletal Disorders

Upper Extremity Disorders
* Carpel tunnel syndrome
* Cubital tunnel syndrome
* Thoracic outlet syndrome
* Raynaud’s syndrome (white finger)
* Rotator cuff syndrome
* DeQuervain’s disease
* Tendinitis
* Tenosynovitis
* Trigger finger
* Ganglion cyst

Neurovascular Disorders
* Carpal Tunnel Syndrome
o Impingement of the median nerve caused by irritation and swelling of the tendons in the carpal tunnel
* Cubital Tunnel Syndrome
o Pressure on the ulnar nerve when the elbows are exposed to hard surfaces

Neurovascular Disorders
* Thoracic Outlet Syndrome
o Compression of the blood vessels between the neck and shoulder caused by reaching above shoulder level or carrying heavy objects

* Raynaud’s Syndrome
o Also known as Vibration White Finger ; Blood vessels of the hand are damaged (narrowed) from repeated exposure to vibration for long periods of time

Tendon Disorders
* Rotator Cuff Syndrome
* DeQuervain’s Disease
o Combination of tendinitis and tenosynovitis
* Tendinitis
o Irritation of the tendon
* Tenosynovitis
o Irritation of the synovial sheath
* Ganglion Cyst
o Accumulation of fluid within the tendon sheaths

Tendinitis
Hand and Wrist
Common Occupational CTDs of the Upper Extremities

Carpal Tunnel Syndrome occurs from chronic swelling of the flexor tendons in the wrist.

The median nerve, which feeds the first three fingers and the thumb, can become impaired from pressure in the carpal tunnel in the wrist.

Symptoms include:

# pain in the first three fingers and the thumb
# numbness in these areas
# tingling in these areas

Carpal Tunnel Syndrome
Common Occupational CTDs of the Upper Extremities

Raynaud’s Syndrome is when blood vessels of the hand are damaged (narrowed) from repeated exposure to vibration for long periods of time

This is connected with use of vibrating tools, such as hair clippers and jack hammers.

Raynaud’s Syndrome
Symptoms

o Numbness and tingling in the fingers during vibration exposure; may continue after exposure has been discontinued
o Blanching (whitening) of one fingertip because of a temporary constriction of blood flow
o Other fingers also blanch
o Intensity of pain & frequency of attacks increase in time

Common Occupational CTDs of the Upper Extremities

Cubital Tunnel Syndrome is caused by resting the elbows on hard surfaces such as unpadded tables or armrests.

The ulnar nerve, which feeds the ring and little fingers, can become impaired from pressure near the elbows.

Symptoms include:
+ pain in the ring and little fingers
+ tingling in these areas
+ numbness in these areas


Cubital Tunnel Syndrome
Common Occupational CTDs of the Upper Extremities
Thoracic Outlet Syndrome is caused by frequent reaching above shoulder level, by carrying heavy objects, or poor posture involving a forward head tilt.

A Neurovascular bundle called the brachial plexus, which passes between the collar bone and the top rib, can become impaired from pressure associated with movements that causes these two bones to be positioned close together.

Symptoms include:
+ the arms “falling asleep”
+ weakened pulse
+ numbness in the fingers

Thoracic Outlet Syndrome
Common Occupational CTDs of the Upper Extremities
Rotator cuff syndrome is a disorder involving swelling and pain of tendons comprising the rotator cuff muscle group:

subscapularis, supraspinatus, infraspinatus, & teres minor

Symptoms include:

o Pain when you bend the arm and rotate it outwards against resistance
o Pain on the outside of the shoulder possibly radiating down into the arm
o Pain in the shoulder, which is worse at night
o Stiffness in the shoulder joint.

Rotator Cuff Syndrome Anterior View Posterior View
Common Occupational CTDs of the Upper Extremities

Tendinitis is a common CTD for the wrist, elbow, and shoulder. It occurs when we continually stress the tendon cables, causing them to become irritable and sore.

Lateral Epicondylitis - “Tennis elbow”

Medial Epicondylitis - “Golfer’s elbow”

Symptoms include:

# point tenderness
# swelling
# tennis elbow, pain radiates down to back of hand
# golfer’s elbow, pain radiates down to back of hand

Tendinitis

Tenosynovitis is swelling of the sheath that covers the tendon from constant rubbing against the tendon.

Symptoms include:
swelling
pain
loss of motion
loss of strength
Tenosynovitis
Trigger Finger is a tendon disorder that occurs when there is a groove in the flexing tendon of the finger

If the tendon becomes locked in the sheath, attempts to move the finger cause snapping or jerking movements

Usually associated with using tools that have handles with hard or sharp edges.

Trigger Finger
Ganglion Cyst is a bump under the skin caused by an accumulation of fluid within the tendon sheath. It is commonly found at the hand and wrist.

Ganglion Cyst

De Quervain’s Disease is an inflammation of the tendon sheath of the thumb attributed to excessive friction between two thumb tendons and their common sheath.

It’s a combination of Tendonitis and Tenosynovitis.

May be caused by twisting and forceful gripping

Symptoms include:

* swelling
* pain at the base of the thumb.

De Quervain’s Disease
Prospective Study of Computer Users
Fredric Gerr, et. al., 2002, “A Prospective Study of Computer Users: 1. Study Design and Incidence of Musculoskeletal Symptoms and Disorders”.

o 632 individuals
o Newly hired into jobs requiring  15 hr/week of computer use
o Were followed for up to 3 years

Primary Results
* Hand/Arm (H/A) & Neck/Shoulder (N/S) MSS and MSD were common among computer users
* More than 50% of users reported MSS during the 1st year after starting a new job
* Most common H/A disorder was DeQuervain’s tendonitis
* Most common N/S disorder was somatic pain syndrome

Common Occupational Injuries of the Back

Strains and sprains are damage to the tendons and ligaments caused by one time exertions such as lifting or carrying heavy objects.

These can lead to very noticeable back pain, but the pain usually begins to subside within a few days

Facet joint pain results from irritation of the area where the ribs meet the spinal column.

Typically, there is muscle swelling in the affected area and it can become very painful to sit or stand up straight. In some cases it may also be difficult to breath deeply.

Disk erosion occurs from prolonged pressure on the spinal disks, which causes them to become permanently compressed.

The space between the vertebrae becomes smaller, which can lead to impingement of the nerve roots leading out from the spine.

Sitting puts more pressure on the spinal disks than standing, and sitting with the back unsupported can lead to high levels of disk pressure.

Disc Erosion

Sciatic nerve impingement, also called sciatica, is common for people who sit for prolonged periods of time.

The sciatic nerve runs from your lower back down the back of your leg and into to your feet.
Swelling in certain muscles in the buttocks can put pressure on the sciatic nerve, causing pain down the leg.

Herniated discs occur when the inner portion of the disc protrudes, putting pressure on the nerve roots leading from the spine.

Pain or numbness in the legs is a common symptom of herniated discs in the lower back.

Herniated/Bulging Disc
QUESTIONS?

Work Related Musculoskeletal Disorders.ppt

Read more...

27 September 2009

Planning, Development of Clinical Trials



Planning of Clinical Trials
Development of a Clinical Trial
Idea
Reviews from the experts(Sponsor or CRO)
First planning meeting (basic design features)
Second planning meeting (draft protocol)
Final protocol (ethical and scientific, signed by a statistician)
Evaluation (scientific review, IRB, funding)
Implementation
Final analysis and publication

Evolution of Trial Structure
* Large cooperative trials (multicenter trials)
* High scientific level protocol
* Well-defined administrative structure
* Control of performance at all levels (SOPs)
* Competent biometric advice (ICH E9)
* Careful ethical considerations

Why Multicenter Trials?
* Small but important effect
* Enhance generalizability of the results
* Bring new treatment to the community

Clinical Trial Protocol
* A detailed plan giving instructions to the study investigators(doctors) about the way

to conduct the study.
o Contributors to the protocol development
+ investigators,
+ medical personnel from the Sponsor or delegated CRO
+ representatives from the study monitoring team
+ project statistician

Crucial Roles of Statisticians
* Design (very important!!!)
* Monitoring
* Analysis
* Reporting
* New statistical methodology

Sophisticated Statistical Techniques
* O’Brien and Fleming Boundaries
* Lan & DeMets “Spending function”
* Equivalence testing
* Repeated measures
* Bayesian methods
* Nonlinear random effect modeling

Functions of Clinical Trial Protocol
* Guideline for the conduct of the trial
* Quality control for all aspects of a clinical trial
* To provide guidelines to the monitoring groups such as: IEC / IDMC.
* Written agreement between:
o the investigator
o the participant,
o and the scientific community
* Legal documents for
o FDA and other regulatory bodies
* To procure funding

Duration of Protocol Development
7days-6months!!!
4-50 pages long!!!

Three Fundamental Aspects
* Which patients are eligible
* Which treatment are to be evaluate
* How each patient’s response is to be assessed

Background
* Rationale
* Unpublished work of the investigators
* Pharmacological and toxicity
* Any new and non standard methods

Specific Objectives
* New treatment
* New indication
* Determine the best of a number of standard treatments
* To provide additional data on safety or efficacy

Methods
o Hypothesis
o Patient population (operational definition)
+ Inclusion Criteria
+ Exclusion Criteria
More homogeneous less generalizable!!

Treatment Regimens
Required procedures for treatment administration, including precise rules for does

determinations

Trial Design
Control groups
+ Define and justify the control group
+ Safety consideration of the placebo group
+ Randomization (verifiable method)
# Method used to generate the allocation schedule
# Method of allocation concealment
* Packing number
* Telephone
* Remote data entry
# Timing of assignment
+ Balance on Prognostic Factors
# Stratification
# Minimization
Blinding
+ Mechanism of treatment blinding
+ Single, double, triple, quadruple blinding
+ Assessment of the effectiveness of blinding

Experimental design
+ Parallel designs
+ Cross-over designs
+ Factorial designs
+ Sequential designs

* Patient management guidelines, including specifications for does reductions, treatment

delays and treatment terminations
* Schedules of required clinical tests and assessments

Follow-up phase
* Schedule of submission of required materials and data, including long-term follow-up
* Data and materials submission procedures

Termination
* Procedures for ending patients’ participation in the trial

Study Flow Diagram
* A flowchart describe how patients progress through the trial
o Initial screening
o Randomization
o Planned schedule
o Follow-up visits
o Early termination

Outcome Measures
* Primary end points
Secondary end points

Statistical Issues
* Power analysis justifying sample size requirements
* Interim monitoring and analysis plans
* Planned time and methodology of final analyses e.g. ITT, PP, NNT, CI
* Methods on secondary aims, compare toxicities

Ethics and Safety
* Protection of the trial patient’s right and safety
o How the patient is approached for entry into the trial
o Regulatory obligations, including informed consent and reporting of adverse

events
o Plan and action if a SAE be detacted

Other Topics in a Study Protocol
* Laboratories
* Compliance
o How compliance is monitored
o Methods used to improve compliance
* Organization
o Roles
o Responsibilities
* Budget
* Study Forms (CRFs) and data handling
* Administrative responsibilities

CRF Design
* Identification data
* Research data
* Administrative data
* Regulatory data

Basic Information in CRF
* Consent dates
* Eligibility checklist
* Baseline assessments
* Dosing of study medications ( incl. compliance)
* Concomitant illness
* Safety
* Effectiveness
* Premature termination of study

Administrative Structure of Multicentre Trials
* Steering Committee
o Leadership body of the investigative group
* Data and Safety Monitoring Committee
o Assess the progress, safety and efficacy
o Recommendations about continue, modify or terminate.

Study Chairman
* Chair steering committee
* Responsible for the overall project
* Overseeing the design and conduct of the trial
* Implementation of SOPs and good clinical practices
* Compliance with international and local regulations.

Coordinating Centre
o Training
o Registration
o Randomization
o Supplying
o Collecting and processing CRFs
o Coordination of accrual sites
o Auditing study sites
o Regulatory reporting

Statistical Centre
o Data entry and processing
o Ongoing monitoring of toxicity data
o Periodical interim analysis of study endpoints
o Final data analyses
o Preparation abstract and manuscripts

Central Laboratory

Other Major Personnel
* Trial statistician
* Clinical research associate
* Data manager
* Randomization specialist
* Quality assurance officer
* Computer support personnel
* Resource Centre Directors
* Training directors
* Field site personnel
* Independent Data Monitoring Committee

Field Site Personnel
* Investigator/Study coordinator
* Research Nurse/
o Participants accrual
o Intervention
o Primary data collection
o Follow-up

Standard Operating Procedures (SOPs)
* To ensure that the specific tasks in the trial are carried out in a consistent manner.
* Topics for SOPs for Investigators:

General Topics
* General quality assurance
* Quality control procedures
* Research personnel qualifications
* Clinical audit
* Regulatory authority inspections

Ethics
* Initial and continuing review by ethics committees
* Informed consent
* Consent forms and information sheets

Study Setup
* Review of:
o investigator brochures
o Protocols
o Protocol amendments
o CRFs
o agreements (e.g. responsibility, financial, confidential, insurance/indemnity

agreement)

Monitoring and Initial Data Review:
* Monitoring visits
* Source data verification
* Data query

Management of Study Medications and Clinical Laboratory Samples:
* Shipment
* Receipt
* Control at study sites
* Dispensing inventory
* Compliance with use of study medication
* Randomization procedures
* Clinical laboratory samples

Safety Event Reporting
* Definitions
* Recording and reporting AEs
* Recording and reporting AEs to ethics committees;

Closing The Study
* Review of clinical study reports
* Premature termination or suspension
* Archiving

Some Important ICH Guidelines
* E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
* E3 Structure and Content of Clinical Study Report (1995)
* E6 Good Clinical Practice (1996)
* E7 Clinical Trials in Special Populations: Geriatrics (1993)
* E8 General Consideration for Clinical Trials (1997)
* E9 Statistical Principles for Clinical Trials (1998)
* E10 Choice of Control Group in Clinical Trials (TBI)
o ICH home page: http://www.ifpma.org/ich1.html
o FDA guidelines: http://www.fda.gov/cder/regulatory/default.htm

Federal Office for Human Research Protections (OHRP)
* OHRP is responsible for monitoring subject protections at more than 4,000 HHS

(Department of Health and Human Services) funded universities, hospitals and other research

institutions.

Investigational Melanoma Vaccine Research Study (MV)- Oklahoma Case
* OHRP Halts Human Research at University of Oklahoma for Subject Protection Violations
* Suspension Date: June 29 2000
* Suspension of 75 federally funded clinical trials performed though the Tulsa campus

Major OHRP Findings:
* MV failure to meet GMP
* allowed for potential subject exposure to bacterial and viral infections.
* 26 of 96 subjects (vaccine arm) died.
* Investigators failed to ensure that risks to subjects were minimized.

Major OHRP Findings:
* Incomplete informed consent documents
o the purpose of the study
o Procedures
o Foreseeable risks and discomforts
o Any expected benefit from study participation
o Overstated the benefits of the study as capable of preventing the recurrence of

melanoma or reducing existing tumor mass
* IRB failure to meet its federal regulatory obligations.
* Implemented substantive changes to the study without obtaining IRB approval.
* Failure to adhere to the protocol inclusion/exclusion criteria.
* Recruited 96 patients with IRB approved size <=40.
* Directly ship study vaccine to some subject’s homes for self-administration.

Actions Taken
* Independent accreditation of a newly formed Tulsa IRB
* Require that sponsor use DSMB as a condition for approval;
* Mandatory certification in human subject protection for those involved in the conduct

of clinical studies
* Educational program specially for clinical investigators, research staffs and IRB

members

Consequences
* Director of the Office of Research resigned
* Chair of IRB retired
* PI (Former Vice Chairman of the University’s dept. of Surgery) has been relieved of

all his administrative duty at the University, which in process of terminating his

appointment as a tenured faculty member.
* Federal lawsuit against
o study’s PI,
o its corporate co-sponsor
o and its IRB members,
* Violations of
o human subject protection regulations,
o international recognized ethical standards for research conduct
o and civil rights laws.

Controlled Clinical Trial
A Journal
* An official journal for the Society for Clinical Trials
* The first issue was published in the May of 1980.
* Aim and scope:
o Basic Design
o Operating features
o Organization
o Analysis

Other Useful Journals
* Applied Clinical Trials
* Statistical Methods in Medical Research
* Statistics in Medicine
* Biometrics

Statistical Principles for Clinical Trials ICH E9
* Considerations for overall clinical development
* Trial design considerations
* Trial conduct considerations
* Data analysis considerations
* Evaluation of safety and Tolerability
* Reporting

Scope of Trials (ICH E9)
* Population
* Primary and Secondary Variables
* Composite variables
* Global Assessment variables
* Multiple Primary Variables
* Surrogate Variables
* Categorized Variables

Design Techniques to Avoid Bias (ICH E9)
* Blinding
* Randomization

Trial Design Considerations (ICH E9)

* Design Configuration
* Parallel Group Design
* Cross-over Design
* Factorial Design
* Mulitcentre Trials

Trial Design Considerations (ICH E9)

* Type of Comparison
o Trials to show superiority
o Trials to show Equivalence or Non-inferiority
o Trials to show Does-response Relationship
* Group sequential designs
* Sample Size
* Data capture and Processing

Trial Conduct Considerations
(ICH E9)
* Trial Monitoring and Interim Analysis
* Changes in Inclusion and Exclusion Criteria
* Accrual Rates
* Sample Size Adjustment
* Interim Analysis and Early stopping
* Role of IDMC

Data Analysis Considerations
(ICH E9)
* Prespecification of the Analysis
* Analysis Sets
o Full Analysis Set
o Per Protocol Set
o Roles of the Different Analysis Sets
* Missing Values and Outliers

Data Analysis Considerations
(ICH E9)
* Data Transformation
* Estimation, CIs and Hypothesis Testing
* Adjustment of Significance and Confidence Levels
* Subgroups, Interactions and Covariates
* Integrity Data and Computer Software Validity

Planning, Development of Clinical Trials.ppt

Read more...

A Randomized Clinical Trial to Prevent Type 2 Diabetes



A Randomized Clinical Trial to Prevent Type 2 Diabetes in Persons at High Risk

The DPP Research Group
Institutions and Investigators
Abbas Kitabchi
U. of Tennessee

Steven Kahn
U. of Washington
Edward Horton
Joslin Diabetes Center

Richard Hamman
U. of Colorado Health Sciences Center

Steven Haffner
U. of Texas Health Science Center and many others

* There is a long period of glucose intolerance that precedes the development of

diabetes
* Screening tests can identify persons at high risk
* There are safe, potentially effective interventions that can address modifiable risk

factors

Feasibility of Preventing
Type 2 Diabetes

Modifiable Risk Factors for
Type 2 Diabetes
* Obesity
* Body fat distribution
* Physical inactivity
* Elevated fasting and 2 hr glucose levels
* To prevent or delay the development of type 2 diabetes in persons with impaired

glucose tolerance (IGT)

DPP Primary Goal
DPP Secondary Goals
* Reduce cardiovascular disease (CVD) events
* Reduce CVD risk factors
* Reduce atherosclerosis

Study Design
* 3-group randomized clinical trial
* 27 clinical sites
* Standardized across clinics:
o Common protocol and procedures manual
o Staff training
o Data quality control program
Eligibility Criteria
Screening and Recruitment
Step 1 screening
Step 2 OGTT
Step 3 start run-in
Step 4 randomization
Number of participants
Step 3 end run-in

The DPP Research Group, Controlled Clin Trials (in press)
Study Interventions
Eligible participants
Randomized
Standard lifestyle recommendations
Intensive Metformin Placebo
Lifestyle
Primary Outcome: Diabetes

* Annual fasting plasma glucose (FPG) and 75 gm Oral Glucose Tolerance Test
o FPG > 126 mg/dL (7.0 mmol/L) or
o 2-hr > 200 mg/dL (11.0 mmol/L),
o Either confirmed with repeat test
* Semi-annual FPG
o > 126 mg/dL, confirmed

Lifestyle Intervention
An intensive program with the following specific goals:
* > 7% loss of body weight and maintenance of weight loss
o Dietary fat goal -- <25% of calories from fat
o Calorie intake goal -- 1200-1800 kcal/day
* > 150 minutes per week of physical activity

Lifestyle Intervention Structure
* 16 session core curriculum (over 24 weeks)
* Long-term maintenance program
* Supervised by a case manager
* Access to lifestyle support staff
o Dietitian
o Behavior counselor
o Exercise specialist

The Core Curriculum
* 16 session course conducted over 24 weeks
* Education and training in diet and exercise methods and behavior modification skills
* Emphasis on:
o Self monitoring techniques
o Problem solving
o Individualizing programs
o Self esteem, empowerment, and social support
o Frequent contact with case manager and DPP support staff

Post Core Program
* Self-monitoring and other behavioral strategies
* Monthly visits
o Must be seen in person at least every two months
* Supervised exercise sessions offered
* Periodic group classes and motivational campaigns
* Tool box strategies
o Provide exercise videotapes, pedometers
o Enroll in health club or cooking class

DPP Study Interventions:
Criteria for Drug Treatment
* Efficacy
* Safety
* Tolerability - minimal side effects
* Acceptability - dose frequency
Metformin- 850 mg per day escalating after
4 weeks to 850 mg twice per day
Placebo- Metformin placebo adjusted in
parallel with active drugs

Interventions:
Medications
DPP Population
Retention and Participation
Lifestyle Intervention: Physical Activity Results
Mean Change in Leisure Physical Activity
Placebo
Metformin
Lifestyle
Effect of Treatment on Incidence of Diabetes
Diabetes Incidence Rates by Age
Diabetes Incidence Rates by Ethnicity
Diabetes Incidence Rates by BMI
Body Mass Index (kg/m2)
Diabetes Incidence Rates by Fasting Glucose
Fasting Plasma Glucose: mg/dl (mmol/l)
Diabetes Incidence Rates by 2-hr Glucose
2-Hour Plasma Glucose (mg/dl)
Consistency of Treatment Effects
Normal Fasting Glucose
Placebo Metformin Lifestyle
Summary-1
* Both interventions were well accepted and safe
* Intensive lifestyle resulted in weight loss and increased activity level for the

duration of the study

Summary-2
* Both interventions were effective in men and women and all ethnic groups
* Intensive lifestyle intervention was effective in all age groups, including those > 60 years of age

Summary-3
* Intensive lifestyle intervention reduced the development of diabetes by 58%
* Metformin reduced the development of diabetes by 31%
* Lifestyle was more effective than metformin

Lipids by Sex and Ethnicity

A Randomized Clinical Trial to Prevent Type 2 Diabetes.ppt

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP